Company Filing History:
Years Active: 2018
Title: Mats Ulfendahl: Innovator in Neurosensory Hearing Loss Treatment
Introduction
Mats Ulfendahl is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of auditory health, particularly in the treatment of neurosensory hearing loss. His innovative approach has led to the development of a unique composition aimed at restoring auditory function.
Latest Patents
Ulfendahl holds a patent for "Sterol derivatives for treating neurosensory hearing loss, and corresponding composition." This invention relates to a composition designed to prevent hearing loss in subjects or to partially restore hearing in individuals with reduced auditory function. The composition includes at least one sterol compound that induces neuron differentiation and is applied to the cochlea.
Career Highlights
Throughout his career, Mats Ulfendahl has worked with various companies, including Affichem and Dendrogenix. His work has focused on advancing treatments that address hearing impairments, showcasing his commitment to improving auditory health.
Collaborations
Ulfendahl has collaborated with notable professionals in his field, including Philippe De Medina and Michaël Paillasse. These partnerships have contributed to the development and refinement of his innovative approaches to hearing loss treatment.
Conclusion
Mats Ulfendahl's contributions to the field of auditory health through his patent and collaborations highlight his dedication to innovation. His work continues to pave the way for advancements in treating neurosensory hearing loss.